Open AccessIntravesical Treatment with Electro-Mediated Administration of Mytomicin C as Prophylaxis for Intermediate and High-Risk Nonmuscle-Invasive Bladder Cancer: A Retrospective Multicenter Study
Author(s) -
Roberto Carando,
Michele Zazzara,
Simone Cotrufo,
Giuseppe M. Ludovico
Publication year - 2019
Publication title -
urologia internationalis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.771
H-Index - 53
eISSN - 1423-0399
pISSN - 0042-1138
DOI - 10.1159/000502663
Subject(s) - medicine , mitomycin c , bladder cancer , clinical endpoint , urology , chemotherapy , retrospective cohort study , surgery , cancer , randomized controlled trial
Topical therapy of nonmuscle-invasive bladder cancer (NMIBC) is based on immunotherapy with Bacillus Calmette-Guerin and chemotherapy administered by passive instillation, but an active drug administration achieves a better concentration of the drugs in the bladder.